Found 6 matching trials
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 PHASE3 This is a phase 3, randomized, multi-center study to evaluate the efficacy ...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals PHASE1 This study will determine if Albumin-linked interferon (Albinterferon alfa-...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients PHASE1 This study will evaluate safety, tolerability, pharmacokinetics and pharmac...
Show More Location
Novartis Pharmaceuticals, Japan
Learn More & Join Trial
Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects PHASE1 This study will assess the efficacy of ABF656 in chronic hepatitis B charac...
Show More Location
Novartis Investigator Site
Learn More & Join Trial
Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients PHASE2 This study will evaluate the safety and efficacy of alb-interferon in adult...
Show More Location
Novartis Investigative site
Learn More & Join Trial
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients PHASE3 This is a phase 3, randomized, multi-center study to evaluate the efficacy ...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial